Skip to content
10-Q

Quarterly Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-23-001118

← back to feed
Filed
Oct 31, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 31, 2023 40.79M sh
Cash And Equivalents Q3 2023 · Sep 30, 2023 $41.99K
Cash And Equivalents Q3 2023 · Dec 31, 2022 $11.57K
Total Liabilities Q3 2023 · Sep 30, 2023 $86.4K
Total Liabilities Q3 2023 · Dec 31, 2022 $48.79K
Current Assets Q3 2023 · Sep 30, 2023 $95K
Current Assets Q3 2023 · Dec 31, 2022 $31.61K
Total Assets Q3 2023 · Sep 30, 2023 $95K
Total Assets Q3 2023 · Dec 31, 2022 $31.61K
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$101.06K
Stockholders Equity Q3 2023 · Sep 30, 2022 −$37.53K
Stockholders Equity Q3 2023 · Jun 30, 2022 −$2.82K
Stockholders Equity Q3 2023 · Mar 31, 2022 −$944
Stockholders Equity Q3 2023 · Dec 31, 2021 −$1.01K
Sga Expense Q3 2023 · Sep 30, 2022 $94.1K
Sga Expense Q3 2023 · Sep 30, 2022 $102.69K
Net Income Q3 2023 · Sep 30, 2022 −$84.7K
Net Income Q3 2023 · Sep 30, 2022 −$90.79K
Net Income Q3 2023 · Jun 30, 2022 −$1.88K
Net Income Q3 2023 · Mar 31, 2022 −$4.21K
Operating Income Q3 2023 · Sep 30, 2022 −$84.7K
Operating Income Q3 2023 · Sep 30, 2022 −$90.79K
Gross Profit Q3 2023 · Sep 30, 2022 $16.4K
Gross Profit Q3 2023 · Sep 30, 2022 $23.68K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $3.33K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $4.38K
Revenue Q3 2023 · Sep 30, 2022 $19.73K
Revenue Q3 2023 · Sep 30, 2022 $28.06K